Skip to content
10-Q

Quarterly Report

JUNIPER PHARMACEUTICALS INC

0001564590-17-021282

← back to feed
Filed
Nov 2, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Oct 31, 2017 10.84M sh
Shares Diluted Q3 2017 · Sep 30, 2017 10.84M sh
Shares Diluted Q3 2017 · Sep 30, 2017 10.82M sh
Shares Diluted Q3 2017 · Sep 30, 2016 11.06M sh
Shares Diluted Q3 2017 · Sep 30, 2016 10.79M sh
Dividends Paid Q3 2017 · Sep 30, 2017 $14K
Dividends Paid Q3 2017 · Sep 30, 2016 $21K
Capex Q3 2017 · Sep 30, 2017 $2.4M
Capex Q3 2017 · Sep 30, 2016 $2.26M
Long Term Debt Q3 2017 · Sep 30, 2017 $3.37M
Long Term Debt Q3 2017 · Dec 31, 2016 $2.2M
Short Term Debt Q3 2017 · Sep 30, 2017 $535K
Short Term Debt Q3 2017 · Dec 31, 2016 $204K
Cash And Equivalents Q3 2017 · Sep 30, 2017 $22.11M
Cash And Equivalents Q3 2017 · Dec 31, 2016 $20.99M
Cash And Equivalents Q3 2017 · Sep 30, 2016 $14.97M
Cash And Equivalents Q3 2017 · Dec 31, 2015 $13.9M
Stockholders Equity Q3 2017 · Sep 30, 2017 $39.91M
Stockholders Equity Q3 2017 · Dec 31, 2016 $39.77M
Current Liabilities Q3 2017 · Sep 30, 2017 $18.33M
Current Liabilities Q3 2017 · Dec 31, 2016 $14.99M
Total Liabilities Q3 2017 · Sep 30, 2017 $21.84M
Total Liabilities Q3 2017 · Dec 31, 2016 $17.25M
Current Assets Q3 2017 · Sep 30, 2017 $36.68M
Current Assets Q3 2017 · Dec 31, 2016 $34.73M
Total Assets Q3 2017 · Sep 30, 2017 $61.76M
Total Assets Q3 2017 · Dec 31, 2016 $57.57M
Eps Diluted Q3 2017 · Sep 30, 2017 −$0.13
Eps Diluted Q3 2017 · Sep 30, 2017 −$0.26
Eps Diluted Q3 2017 · Sep 30, 2016 $0.02
Eps Diluted Q3 2017 · Sep 30, 2016 −$0.34
Eps Basic Q3 2017 · Sep 30, 2017 −$0.13
Eps Basic Q3 2017 · Sep 30, 2017 −$0.26
Eps Basic Q3 2017 · Sep 30, 2016 $0.02
Eps Basic Q3 2017 · Sep 30, 2016 −$0.34
Sga Expense Q3 2017 · Sep 30, 2017 $3.24M
Sga Expense Q3 2017 · Sep 30, 2017 $12.26M
Sga Expense Q3 2017 · Sep 30, 2016 $3.11M
Sga Expense Q3 2017 · Sep 30, 2016 $9.82M
Rd Expense Q3 2017 · Sep 30, 2017 $2.29M
Rd Expense Q3 2017 · Sep 30, 2017 $5.29M
Rd Expense Q3 2017 · Sep 30, 2016 $2.3M
Rd Expense Q3 2017 · Sep 30, 2016 $8.23M
Net Income Q3 2017 · Sep 30, 2017 −$1.41M
Net Income Q3 2017 · Sep 30, 2017 −$3.23M
Net Income Q3 2017 · Sep 30, 2016 $248K
Net Income Q3 2017 · Sep 30, 2016 −$3.66M
Operating Income Q3 2017 · Sep 30, 2017 −$1.54M
Operating Income Q3 2017 · Sep 30, 2017 −$3.35M
Operating Income Q3 2017 · Sep 30, 2016 $177K
Operating Income Q3 2017 · Sep 30, 2016 −$3.84M
Gross Profit Q3 2017 · Sep 30, 2017 $5.27M
Gross Profit Q3 2017 · Sep 30, 2017 $16.26M
Gross Profit Q3 2017 · Sep 30, 2016 $5.85M
Gross Profit Q3 2017 · Sep 30, 2016 $15.12M
Cost Of Revenue Q3 2017 · Sep 30, 2017 $7.72M
Cost Of Revenue Q3 2017 · Sep 30, 2017 $21.93M
Cost Of Revenue Q3 2017 · Sep 30, 2016 $5.71M
Cost Of Revenue Q3 2017 · Sep 30, 2016 $18.52M
Revenue Q3 2017 · Sep 30, 2017 $12.99M
Revenue Q3 2017 · Sep 30, 2017 $38.19M
Revenue Q3 2017 · Sep 30, 2016 $11.56M
Revenue Q3 2017 · Sep 30, 2016 $33.64M